MARKET

KRTX

Karuna Therapeutics
KRTX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-47.8397
19176.16
10.01
12,599,265,883.76
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies. The drugmaker gained access to the treatment, called KarXT, through its $14 billion deal to buy Karuna Therapeutics last year. Long-term data of the drug reinforced findings of previous studies.
Reuters · 04/06 17:15
3 Potential Biotech Buyout Targets In 2024
Biotech sector saw a surge of M&A activity at the end of 2023. The small biotech sector surged by 50% off its late October lows. 2024 should be a solid year for acquisitions in the biotech/biopharma space. Big drug makers have large cash balances and face key patent expirations. Three potential buyout targets in 2024 are highlighted below.
Seeking Alpha · 03/19 14:16
Strike While The Market Is Hot
Companies are taking advantage of strong investor demand in the investment grade credit market. In the first two months of 2024, nearly 200 companies issue roughly $380 billion of new bonds in the U.S. Investment grade primary market. Monthly issuance totals for both January and February blew away the prior three-year averages of $138 billion.
Seeking Alpha · 03/19 05:45
Karuna Therapeutics: Statement of changes in beneficial ownership of securities
Press release · 03/18 22:38
*News On Karuna Therapeutics Inc. (KRTX) Now Under BMY
Dow Jones · 03/18 21:08
Karuna Therapeutics Undergoes Extensive Corporate Transformation
TipRanks · 03/18 13:23
*Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
Dow Jones · 03/18 12:44
Weekly Report: what happened at KRTX last week (0311-0315)?
Weekly Report · 03/18 11:43
More

Webull offers Karuna Therapeutics stock information, including NASDAQ: KRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRTX stock methods without spending real money on the virtual paper trading platform.